MARKET

LTRN

LTRN

Lantern Pharma Inc
NASDAQ
9.75
-0.28
-2.75%
Opening 13:06 03/27 EDT
OPEN
10.05
PREV CLOSE
10.03
HIGH
10.47
LOW
9.13
VOLUME
207.87K
TURNOVER
0
52 WEEK HIGH
11.99
52 WEEK LOW
2.380
MARKET CAP
104.77M
P/E (TTM)
-6.6259
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at LTRN last week (0318-0322)?
Weekly Report · 2d ago
Lantern Pharma’s Triple Threat: Inflation, Global Tensions, and Pandemic Impacts Jeopardize Financial Health
TipRanks · 03/20 06:02
BUZZ-U.S. STOCKS ON THE MOVE-US energy sector, Avis, NuScale
The tech-laden Nasdaq dipped on Tuesday with chip stocks falling to more than two-week lows. The Dow Jones Industrial Average was up 0.67% as focus turned to the Federal Reserve's policy meeting. The top three S&P 500 percentage gainers were International Paper Co, up 10%.
Reuters · 03/19 17:48
12 Health Care Stocks Moving In Tuesday's Intraday Session
Ontrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. Fusion Pharmaceuticals stock moved upwards by 97%. SCWorx stock rose 70.74% and Enliven Therapeutics stock increased by 29.19%. Acutus Medical stock declined by 26.5% during the session.
Benzinga · 03/19 17:31
OTRK, STRC and APM among mid-day movers
On the Move OTRK, STRC and APM among mid-day movers. Fusion Pharmaceuticals (FUSN) and Ontrak (OTRK) are among the Gainers. NuScale Power Corporation (SMR) is among the losers.
Seeking Alpha · 03/19 16:48
BUZZ-U.S. STOCKS ON THE MOVE-National Cinemedia, Crinetics Pharma, Nordstrom
The S&P 500 and the Nasdaq fell on Tuesday with most megacap and chip stocks weakening. The Dow Jones Industrial Average was up 0.56%. National Cinemedia, Crinetics Pharma, Nordstrom were up. The top three Nasdaq percentage gainers were International Paper, Boeing and Boeing.
Reuters · 03/19 16:05
Graphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare movers
Graphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare movers. S&P 500 Health Care Sector -0.02% to 1689.96. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index is +0.01% to 1378.25.
Seeking Alpha · 03/19 14:00
H.C. Wainwright Reaffirms Their Hold Rating on Lantern Pharma (LTRN)
H.C. Wainwright analyst Emily Bodnar maintained a Hold rating on Lantern Pharma. The company’s shares closed yesterday at $9.96. Bodnar covers the Healthcare sector and has an average return of 13.8%. Lantern Pharma is a clinical-stage biotechnology company. The analyst consensus on the company is currently a Hold.
TipRanks · 03/19 10:29
More
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical-stage drug programs. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 60 billion oncology-focused data points and a library of over 200 advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.

Webull offers Lantern Pharma Inc stock information, including NASDAQ: LTRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LTRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LTRN stock methods without spending real money on the virtual paper trading platform.